speb/financial-data huggingface dataset:
POLYMED.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Payables: 1309902000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Pension And Employee Benefit Expense: 21144000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 331910000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 152337000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Pretax Income: 3442691000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 11262000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -2770159000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 1335186000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 6043163000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 639265000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 22265000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 22265000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Research And Development: 194423000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 4125000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 7308518000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 19163000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 263654000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 473246000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Share Issued: 95971417.00
POLYMED.NS income_statement (annual, 2024-03-31) — Special Income Charges: -5599000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 14700535000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 14164779000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 51318861.30
POLYMED.NS income_statement (annual, 2024-03-31) — Tax Provision: 860094000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.25
POLYMED.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 172761000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -743013000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Total Assets: 18586719000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 14708940000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Total Debt: 1739047000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 14700535000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Total Expenses: 10630392000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 3886184000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 10170685000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 374040000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 14116000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 35597000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 203889000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 203889000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Work In Process: 452576000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Working Capital: 4903890000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Write Off: 11827000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 1450568000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 3283713000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 348630000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 30331000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 506453000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 130861000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 12641549000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 506453000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 25912630000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 623599000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 19240456000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 17962000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 1564789000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 1582751000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 4169945000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 8343000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 285811000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 551395000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 9792136000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 2698370000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 27488576000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Investment Properties: 0.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 348630000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 12369000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 11157000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 23526000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 94260000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 99723000.00
POLYMED.NS income_statement (quarterly, 2024-09-30) — Minority Interests: 0.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 1445085000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 9792136000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 25361235000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Revenue: 20310000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 289048000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 101290565.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 612986000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 233159000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 25406177000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 265584000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 495761000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 9168537000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 3838000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 12510688000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Payables: 1501478000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 101290565.00
POLYMED.NS income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 25912630000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 25361235000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 30522636000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 25923787000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 1606277000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 25912630000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 4610006000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 11282182000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 440061000.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 50910000.00
POLYMED.NS income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
POLYMED.NS income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
POLYMED.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 15070511000.00
POLYMED.NS income_statement (quarterly, 2024-12-31) — Minority Interests: 0.00
POLYMED.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
POLYMED.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
POLYMED.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
POLYMED.NS income_statement (annual, 2025-03-31) — +Operating Expense: 7441850000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 1942508000.00
POLYMED.NS income_statement (annual, 2025-03-31) — +Total Revenue: 16698316000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 4408282000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 864191000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 864191000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 3497324000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 3497324000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -4861207000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -4861207000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 13783354000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 13783354000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -61763000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -61763000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Amortization: 32948000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 32948000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 202422000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 202422000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 99196367.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 102953139.00
POLYMED.NS income_statement (annual, 2025-03-31) — Basic EPS: 34.13
POLYMED.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 8.92
POLYMED.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 120531000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 2577714000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 2577714000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -3310254000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 25955000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 25955000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 506629000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 506629000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 86988000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 86988000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 12074987000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 12074987000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -303409000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 86988000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 86988000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -645423000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -113336000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 102691000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Change In Payable: -71788000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -837525000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -1553418000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -36266000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Common Stock: 506629000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 506629000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 27656579000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 27656579000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 10003513000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 1377411000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1377411000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 5554427000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1481456000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Current Assets: 19169971000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 19169971000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 18242000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 18242000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Current Debt: 1776499000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 1776499000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 1794741000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1794741000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 68471000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 68471000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 3701692000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 3701692000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 3990000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 3990000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Depreciation: 831822000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 831822000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 831822000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 211684000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 831822000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 211684000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 99254529.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 102953139.00
POLYMED.NS income_statement (annual, 2025-03-31) — Diluted EPS: 34.11
POLYMED.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 8.92
POLYMED.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 3385572000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 918342000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 4588000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 4588000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 24128000.00
POLYMED.NS income_statement (annual, 2025-03-31) — EBIT: 4645116000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — EBIT: 1250165000.00
POLYMED.NS income_statement (annual, 2025-03-31) — EBITDA: 5476938000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — EBITDA: 1461849000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — End Cash Position: 86988000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 9505058000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 446820000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 446820000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -979757000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -439957000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -1203000.00
POLYMED.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 227356000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Goodwill: 285811000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 285811000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 551953000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 551953000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 3559087000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 3559087000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 16644074000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 16644074000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Gross Profit: 11143889000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 2926826000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Interest Expense: 119965000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 21673000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 119965000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 21673000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Interest Income: 117828000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 117828000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -112515000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 126701000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Inventory: 2855727000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 2855727000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 29433078000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 29433078000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -11871821000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 0.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 0.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 202422000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 202422000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Investmentsin Associatesat Cost: 132331000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 132331000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 10003513000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 1565408000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 1565408000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 7713000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 7713000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 0.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 0.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 7713000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 7713000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 132331000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 132331000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 94265000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 94265000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 11099527000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 11099527000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 0.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 0.00
POLYMED.NS income_statement (annual, 2025-03-31) — Minority Interests: 0.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 0.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 10003513000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Net Debt: 1689511000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 1689511000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -14792000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Net Income: 3385572000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Net Income: 918342000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 3385572000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 918342000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 3385572000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 918342000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 3385572000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 918342000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 3385572000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 918342000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 4525151000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 3385572000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 918342000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Net Interest Income: -119965000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -21673000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -8726200000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 85854000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 85854000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -119965000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -21673000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Net PPE: 11782867000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 11782867000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -3296450000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 27104626000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 27104626000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 29548000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 29548000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 3234000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 3234000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 428655000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 428655000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 94265000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 94265000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 73047000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 73047000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 5476938000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 1461849000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Normalized Income: 3385572000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 918342000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 2330497000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Operating Income: 3702039000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Operating Income: 984318000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Operating Revenue: 16698316000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 4408282000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 101325715.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 101325715.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: 2723000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 237310000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 237310000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 1781000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 1781000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 22828000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 22828000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 266142000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 266142000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 129938000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 129938000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -88499000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 3000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 3000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: -1000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: -1000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 891276000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 243095000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 3354459000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 877146000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Other Payable: 405700000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 405700000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Other Properties: 24014000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 24014000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 100355000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 100355000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 11987999000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 11987999000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Other Special Charges: -1203000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Payables: 1274479000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Payables: 1274479000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Pension And Employee Benefit Expense: 12240000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 447259000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 447259000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 206638000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 206638000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Pretax Income: 4525151000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 1228492000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 31755000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: 0.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -3310254000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 1778341000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 1778341000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 5554427000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1481456000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 831822000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 211684000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 26460000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 26460000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Research And Development: 240249000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Research And Development: 64770000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 4588000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 4588000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 10136370000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 10136370000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 13804000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 425524000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 652880000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Share Issued: 101325715.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 101325715.00
POLYMED.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 27656579000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 27656579000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 27104626000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 27104626000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
POLYMED.NS income_statement (annual, 2025-03-31) — Tax Provision: 1139579000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 310150000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.25
POLYMED.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.25
POLYMED.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 193042000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 193042000.00
POLYMED.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -924121000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Total Assets: 31924522000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 31924522000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 27656579000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 27656579000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Total Debt: 1802454000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 1802454000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 27656579000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 27656579000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Total Expenses: 12996277000.00
POLYMED.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 3423964000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 4267943000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 4267943000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 12754551000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 12754551000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 566251000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 566251000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 10708000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 68471000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 68471000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
POLYMED.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Work In Process: 500628000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 500628000.00
POLYMED.NS balance_sheet (annual, 2025-03-31) — Working Capital: 15468279000.00
POLYMED.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 15468279000.00
POLYMED.NS income_statement (annual, 2025-03-31) — Write Off: 3321000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 1930992000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 4032107000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 101287160.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 9.19
POLYMED.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1272303000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 232576000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 232576000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 101508070.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 9.17
POLYMED.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 930829000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — EBIT: 1258964000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — EBITDA: 1491540000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 2759804000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 29501000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 29501000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 0.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Net Income: 930829000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 930829000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 930829000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 930829000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 930829000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 930829000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -29501000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -29501000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 1491540000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 930829000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Operating Income: 828812000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 4032107000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 416909000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 880471000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 1229463000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1272303000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 232576000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Research And Development: 66805000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 298634000.00
POLYMED.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.24
POLYMED.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 3203295000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 2184698000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 4438816000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1168398000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 4257408000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 210116000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 101363135.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 9.06
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 33759000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 506797000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 264430000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 11062859000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 506797000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 29183496000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 830787000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1356580000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 19470473000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 20256000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 2361790000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 2382046000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 5011493000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 4892000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 249308000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 249308000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 101363135.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 9.06
POLYMED.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 918350000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — EBIT: 1246630000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — EBITDA: 1495938000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 2171498000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 2834174000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 12385988000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 3082236000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 29727000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 29727000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 3465228000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 31545286000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Investment Properties: 0.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 210116000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 13503000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 0.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 13503000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 162262000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 122678000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 141200000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Minority Interests: 375000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 2097360000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Net Income: 918350000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 918350000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 917975000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 918350000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 918350000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 917975000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -29727000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -29727000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 12385988000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 26349322000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 19091000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 3643000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 529182000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 1495938000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 918350000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Operating Income: 897538000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 4438816000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 101359490.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 679100000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 300718000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 28676699000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 662676000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 805160000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 141824000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 339443000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 969062000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 11555201000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 5878000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 10798429000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Payables: 1294027000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 1216903000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1356580000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 249308000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Research And Development: 78065000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 101359490.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 29183496000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 26349322000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 298928000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 35871817000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 29183496000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 2395549000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 29324696000.00
POLYMED.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 3541278000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 6547121000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 16401343000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1535628000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 125629000.00
POLYMED.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 14458980000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 2554677000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 4936555000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 101328857.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 7.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 3125374000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 287558000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 287558000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 101473820.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 6.99
POLYMED.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 709302000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — EBIT: 1035717000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — EBITDA: 1323275000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 1811181000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 59592000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 59592000.00
POLYMED.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 1213000.00